Seger Surgical Solutions

Seger Surgical Solutions is developing a laparoscopic bowel anastomosis device to easily and quickly create anastomosis in an intracorporeal procedure.

Seger’s Novel Solution

The Seger Surgical device enables the surgeon to use a standard 12 millimeter trocar to perform the procedure. With the device more surgeons will be able to perform intracorporeal procedures and take advantage of the benefits offered from a fully laparoscopic approach.

  • Decreased length of hospital stay (~½-2 days shorter)
  • Overall reduction in post op morbidity
  • Smaller extraction incisions
  • Decreased pain
  • No bowel twisting (eliminating the need for additional surgery)

The Seger Opportunity

The Seger system allows surgeons to perform bowel resection in a fully laparoscopic procedure for improved clinical results, fewer complications, and reduced healthcare costs.

The Team

  • Kobby Greenberg, CEO: 15+ years’ experience in medical device industry; former positions include CEO Cleanoscope, VP R&D Niti Surgical, mechanical design consultant for KG Holdings
  • Prof. Barry Salky, Co-founder and Medical Director: Internationally recognized pioneer and key opinion leader in the laparoscopic surgical field; developed techniques now considered standard of practice; founder, Laparoscopic Surgery Division, Mount Sinai Hospital, NYC;  secretary of SAGES Foundation; Past VP of SAGES, President of the International Federation of Surgical Endoscopic Societies (IFSES)
  • Leo R. Mindick, Co-founder & Investor: Founder and CEO, Med-Tech Consultant Partners; years of experience in specialty medical devices, IP, regulatory, reimbursement; founder and former CEO multimillion-dollar specialty medical distribution company (later acquired)
  • David Hazzan, M.D. Clinical Director: Chief, Department of Surgery B, Carmel Medical Center, Israel; responsible for preclinical and clinical trials

Scientific Advisory Board

Seger’s multinational advisory board comprises —

  • Ho-Seong Han, M.D., Ph.D.: Seoul National University Bundang Hospital, Korea
  • Armando Melani, M.D.: IRCAD, Rio de Janeiro, Brazil
  • Jungi Okuda, M.D.: Osaka Medical College, Japan
  • Alessio Pigazzi, M.D., Ph.D.: University of California, Irvine, United States
  • Natan Zundel, M.D.: Florida International University Herbert Wertheim College of Medicine, United States

Status

Founded: December 2016
Stage:
Technology development
Investor: The Trendlines Group
IP: 2 U.S. patents; 2 national phase

Background & Market

Bowel resection surgery involves removing all or part of the bowel (the intestine). Often, surgery is the result of colon cancer or gastric bypass surgery.

While laparoscopic surgery is the preferred technique for performing resection, it is not fully laparoscopic: In 90% of these procedures, the final stage involves performing extracorporeal anastomosis (connecting the two bowel ends outside the body). This involves lifting and removing the bowel through the laparoscopic incision, creating the anastomosis outside the body, returning the bowel to its place, and closing the incision.

Today, creating the anastomosis inside the body (intracorporeal) is extremely complex and requires highly skilled surgeons.

The result: increased hospitalization costs due to more post-operative complications and longer hospital stays.

According to Millenium Research Group, U.S. Market for Laparoscopic Devices 2013, the number of bowel resections is expected to exceed 980,000 in the United States and EU by 2020, with an annual growth of 10%, representing a $600 million market.

minimally invasive surgery
Anastomotic closure device for laparoscopic bowel resection

Contact

Kobby Greenberg, CEO
+972.52.281.1935
kobby@seger-surgical.com
Seger Surgical logo

Font Resize
Contrast